 BOSTON, Jan. 07, 2021 GLOBE NEWSWIRE -- X4 Pharmaceuticals, Inc. Nasdaq: XFOR, a leader in the discovery and development of novel therapies targeting diseases resulting from dysfunction of the CXCR4 pathway, today announced that management will present at the H.C. Wainwright Virtual BioConnect Conference being held from January 11-14, 2021. A webcast of the on-demand presentation will be available on the investor section of the X4 Pharmaceuticals website at and at Presentation Webcast Link , beginning on Monday, January 11, 2021. 